Casio to Release Lightweight Mechanical Watch with Excellent Readability

TOKYO, Oct. 29, 2026 /PRNewswire/ — Casio Computer Co., Ltd. announced the…

TIER IV and NTRO advance autonomous transit initiative in Australia

TOKYO, Oct. 29, 2026 /PRNewswire/ — Australia’s National Transport Research Organisation (NTRO)…

Taroko Sports and Gimmatek Unveil SWING X AI Swing Analysis System

11 units deployed across Taiwan and the United States as Taroko launches…

VeriSilicon Introduces GLTiny™ 3D GPU Programming Model for Ultra-Low-Power, Memory-Efficient Wearable Devices

Optimized GLTiny Model Brings Rich 3D Graphics to Resource-Constrained Wearable Devices Powered…

Coremail Strengthens Digital Ecosystem Ties at WPS Indonesia Roundtable 2026

JAKARTA, Indonesia, Oct. 29, 2026 /PRNewswire/ — Coremail, an established provider of…

Straits Financial Services Pte Ltd Participates in First Trading Day of LME Steel HRC Shanghai Futures

SINGAPORE, Oct. 29, 2026 /PRNewswire/ — Straits Financial Services Pte Ltd (SFSPL), a…

Coremail Strengthens Digital Ecosystem Ties at WPS Indonesia Roundtable 2026

JAKARTA, Indonesia, Oct. 29, 2026 /PRNewswire/ — Coremail participated in the WPS…

Ascletis' Oral Small Molecule GLP-1, ASC30, Demonstrated Placebo-Adjusted HbA1c Reduction of 1.7% at 12 Weeks from Its U.S. Phase II Study in Participants with Diabetes

– ASC30 reduced HbA1c by a placebo-adjusted 1.7%, 1.6% and 1.7% from…